Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cell projection morphogenesis	MAP1B MYO5B RTN4 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 RIMS1 TSC22D4 MUC3A PLXNA1 EPHA8	2.34e-05	826	107	15	GO:0048858
GeneOntologyBiologicalProcess	developmental growth involved in morphogenesis	MAP1B MYO5B RTN4 PUM2 DCC TRPV2 RIMS1 TSC22D4 PLXNA1	2.59e-05	299	107	9	GO:0060560
GeneOntologyBiologicalProcess	developmental cell growth	MAP1B MYO5B RTN4 PUM2 DCC TRPV2 RIMS1 TSC22D4 PLXNA1	2.73e-05	301	107	9	GO:0048588
GeneOntologyBiologicalProcess	axon development	MAP1B MYO5B RTN4 PUM2 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 PLXNA1 EPHA8	2.82e-05	642	107	13	GO:0061564
GeneOntologyBiologicalProcess	axonogenesis	MAP1B MYO5B RTN4 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 PLXNA1 EPHA8	3.76e-05	566	107	12	GO:0007409
GeneOntologyBiologicalProcess	regulation of extent of cell growth	MAP1B MYO5B RTN4 PUM2 DCC TRPV2	4.20e-05	122	107	6	GO:0061387
GeneOntologyBiologicalProcess	cytoplasmic pattern recognition receptor signaling pathway	RTN4 PUM2 NLRP3 EPG5 NLRP6 HCFC2 ZC3HAV1	5.65e-05	188	107	7	GO:0002753
GeneOntologyBiologicalProcess	regulation of axonogenesis	MAP1B MYO5B RTN4 DCC TRPV2 DIXDC1 PLXNA1	6.46e-05	192	107	7	GO:0050770
GeneOntologyBiologicalProcess	neuron projection morphogenesis	MAP1B MYO5B RTN4 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 RIMS1 TSC22D4 PLXNA1 EPHA8	6.86e-05	802	107	14	GO:0048812
GeneOntologyBiologicalProcess	positive regulation of cell development	VEGFC PDE3A MAP1B MYO5B RTN4 NLRP3 BNC1 VCAN TRPV2 AKAP11 DIXDC1 PLXNA1	8.20e-05	614	107	12	GO:0010720
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	MAP1B MYO5B RTN4 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 RIMS1 TSC22D4 PLXNA1 EPHA8	8.58e-05	819	107	14	GO:0120039
GeneOntologyBiologicalProcess	neuron projection extension	MAP1B MYO5B RTN4 TRPV2 RIMS1 TSC22D4 PLXNA1	1.03e-04	207	107	7	GO:1990138
GeneOntologyBiologicalProcess	cell morphogenesis	MAP1B MYO5B RTN4 DCC PTCH1 TENM2 FAM171A1 HEG1 NRXN3 CNTN5 TRPV2 DIXDC1 RIMS1 TSC22D4 MUC3A PLXNA1 EPHA8	1.36e-04	1194	107	17	GO:0000902
GeneOntologyBiologicalProcess	immune response-activating signaling pathway	RTN4 PUM2 NLRP3 ITK EPG5 NLRP6 IGKC PAWR PLCG1 HCFC2 ZC3HAV1	1.41e-04	553	107	11	GO:0002757
GeneOntologyBiologicalProcess	maintenance of animal organ identity	ADGRV1 USH2A	2.64e-04	5	107	2	GO:0048496
GeneOntologyBiologicalProcess	positive regulation of axonogenesis	MAP1B MYO5B TRPV2 DIXDC1 PLXNA1	3.21e-04	114	107	5	GO:0050772
GeneOntologyBiologicalProcess	neuron projection development	MAP1B RASGRF1 MYO5B RTN4 PUM2 ADGRV1 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 RIMS1 TSC22D4 PLXNA1 EPHA8	3.23e-04	1285	107	17	GO:0031175
GeneOntologyBiologicalProcess	regulation of neurogenesis	VEGFC MAP1B MYO5B RTN4 DCC CASZ1 VCAN TRPV2 DIXDC1 PLXNA1	3.48e-04	515	107	10	GO:0050767
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	RTN4 PUM2 NLRP3 ITK EPG5 NLRP6 IGKC PAWR PLCG1 HCFC2 ZC3HAV1	3.52e-04	615	107	11	GO:0002764
GeneOntologyBiologicalProcess	activation of immune response	RTN4 PUM2 NLRP3 ITK EPG5 NLRP6 IGKC PAWR PLCG1 HCFC2 ZC3HAV1	3.93e-04	623	107	11	GO:0002253
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	MAP1B MYO5B RTN4 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 PLXNA1 EPHA8	5.02e-04	748	107	12	GO:0048667
GeneOntologyBiologicalProcess	neuron development	MAP1B RASGRF1 MYO5B RTN4 PUM2 ADGRV1 DCC PTCH1 TENM2 NRXN3 CNTN5 TRPV2 DIXDC1 DCLK2 RIMS1 TSC22D4 PLXNA1 EPHA8	5.06e-04	1463	107	18	GO:0048666
GeneOntologyBiologicalProcess	positive regulation of neurogenesis	VEGFC MAP1B MYO5B RTN4 VCAN TRPV2 DIXDC1 PLXNA1	5.19e-04	354	107	8	GO:0050769
GeneOntologyBiologicalProcess	regulation of cell development	VEGFC PDE3A MAP1B MYO5B RTN4 DCC CASZ1 NLRP3 BNC1 VCAN TRPV2 AKAP11 DIXDC1 KAT6B PLXNA1	5.23e-04	1095	107	15	GO:0060284
GeneOntologyCellularComponent	growth cone membrane	DCC TRPV2 EXOC7	1.07e-05	9	107	3	GO:0032584
GeneOntologyCellularComponent	growth cone	MAPK8IP1 MAP1B RASGRF1 DCC PTCH1 TENM2 TRPV2 EXOC7	3.81e-05	245	107	8	GO:0030426
GeneOntologyCellularComponent	site of polarized growth	MAPK8IP1 MAP1B RASGRF1 DCC PTCH1 TENM2 TRPV2 EXOC7	4.79e-05	253	107	8	GO:0030427
GeneOntologyCellularComponent	somatodendritic compartment	CYBB MAPK8IP1 MAP1B RASGRF1 MYO5B RTN4 PUM2 APOB PTCH1 LRRC4 TENM2 PAWR DIXDC1 TSC22D4 SLC24A1 USH2A DYNC1H1 EPHA8	4.87e-05	1228	107	18	GO:0036477
GeneOntologyCellularComponent	distal axon	MAPK8IP1 MAP1B RASGRF1 DCC PTCH1 TENM2 TRPV2 DIXDC1 EXOC7 USH2A	7.99e-05	435	107	10	GO:0150034
GeneOntologyCellularComponent	axonal growth cone	MAPK8IP1 DCC PTCH1 TRPV2	8.22e-05	45	107	4	GO:0044295
GeneOntologyCellularComponent	USH2 complex	ADGRV1 USH2A	1.55e-04	4	107	2	GO:1990696
GeneOntologyCellularComponent	cell body	CYBB MAPK8IP1 MAP1B RASGRF1 MYO5B RTN4 PUM2 APOB TRPV2 PAWR DIXDC1 SLC24A1 USH2A DYNC1H1	2.76e-04	929	107	14	GO:0044297
GeneOntologyCellularComponent	neuronal cell body	CYBB MAPK8IP1 MAP1B RASGRF1 MYO5B RTN4 PUM2 APOB PAWR DIXDC1 SLC24A1 USH2A DYNC1H1	3.40e-04	835	107	13	GO:0043025
GeneOntologyCellularComponent	stereocilia ankle link	ADGRV1 USH2A	3.84e-04	6	107	2	GO:0002141
GeneOntologyCellularComponent	stereocilia ankle link complex	ADGRV1 USH2A	3.84e-04	6	107	2	GO:0002142
GeneOntologyCellularComponent	stereocilium membrane	ADGRV1 USH2A	3.84e-04	6	107	2	GO:0060171
GeneOntologyCellularComponent	periciliary membrane compartment	ADGRV1 USH2A	3.84e-04	6	107	2	GO:1990075
GeneOntologyCellularComponent	hippocampal mossy fiber	MAPK8IP1 MAP1B	5.36e-04	7	107	2	GO:0097457
GeneOntologyCellularComponent	axon	MAPK8IP1 MAP1B RASGRF1 DCC PTCH1 TENM2 CNTN5 TRPV2 PAWR DIXDC1 EXOC7 USH2A DYNC1H1	6.27e-04	891	107	13	GO:0030424
GeneOntologyCellularComponent	stereocilia coupling link	ADGRV1 USH2A	7.12e-04	8	107	2	GO:0002139
GeneOntologyCellularComponent	extrinsic component of synaptic membrane	DNAJC6 TENM2 RIMS1	7.57e-04	35	107	3	GO:0099243
GeneOntologyCellularComponent	dendritic growth cone	MAPK8IP1 PTCH1	1.66e-03	12	107	2	GO:0044294
Domain	Ceramidse_alk_C	ASAH2 ASAH2B	3.07e-05	2	104	2	PF17048
Domain	Vitellinogen_b-sht_N	APOB MTTP	3.07e-05	2	104	2	IPR015816
Domain	Lipid_transp_b-sht_shell	APOB MTTP	3.07e-05	2	104	2	IPR015819
Domain	-	APOB MTTP	3.07e-05	2	104	2	2.30.230.10
Domain	VITELLOGENIN	APOB MTTP	3.07e-05	2	104	2	PS51211
Domain	LPD_N	APOB MTTP	3.07e-05	2	104	2	SM00638
Domain	Lipid_transpt_N	APOB MTTP	3.07e-05	2	104	2	IPR001747
Domain	NEUT/ALK_ceramidase_C	ASAH2 ASAH2B	3.07e-05	2	104	2	IPR031331
Domain	-	APOB MTTP	3.07e-05	2	104	2	1.25.10.20
Domain	Vitellogenin_N	APOB MTTP	3.07e-05	2	104	2	PF01347
Domain	Cl_channel-K	CLCNKA CLCNKB	3.07e-05	2	104	2	IPR002250
Domain	Ceramidase_alk	ASAH2 ASAH2B	3.07e-05	2	104	2	IPR006823
Domain	FN3	FLNC DCC PTPRB CNTN5 HCFC2 USH2A EPHA8	7.90e-05	185	104	7	SM00060
Domain	Vitellinogen_superhlx	APOB MTTP	9.18e-05	3	104	2	IPR011030
Domain	FN3_dom	FLNC DCC PTPRB CNTN5 HCFC2 USH2A EPHA8	1.69e-04	209	104	7	IPR003961
Domain	fn3	DCC PTPRB CNTN5 HCFC2 USH2A EPHA8	2.92e-04	162	104	6	PF00041
Domain	SH3_1	MAPK8IP1 NEB ITK ASAP2 SRGAP1 PLCG1	3.12e-04	164	104	6	PF00018
Domain	EGF	ADAM32 TENM2 HEG1 NRXN3 ADGRE3 VCAN MUC3A	3.45e-04	235	104	7	SM00181
Domain	EGF_3	ADAM32 TENM2 HEG1 NRXN3 ADGRE3 VCAN MUC3A	3.45e-04	235	104	7	PS50026
Domain	EGF-like_dom	ADAM32 TENM2 HEG1 NRXN3 ADGRE3 VCAN MUC3A	4.87e-04	249	104	7	IPR000742
Domain	EGF_1	ADAM32 TENM2 HEG1 NRXN3 VCAN USH2A MUC3A	5.62e-04	255	104	7	PS00022
Domain	TAAR_fam	TAAR8 TAAR6	6.33e-04	7	104	2	IPR009132
Domain	EGF-like_CS	ADAM32 TENM2 HEG1 NRXN3 VCAN MUC3A EPHA8	6.44e-04	261	104	7	IPR013032
Domain	EGF_2	ADAM32 TENM2 HEG1 NRXN3 VCAN MUC3A EPHA8	7.05e-04	265	104	7	PS01186
Domain	FN3	DCC PTPRB CNTN5 HCFC2 USH2A EPHA8	8.66e-04	199	104	6	PS50853
Domain	GPS	ADGRV1 PKD1L3 ADGRE3	8.85e-04	34	104	3	SM00303
Domain	GPS	ADGRV1 PKD1L3 ADGRE3	9.64e-04	35	104	3	PF01825
Domain	GPS	ADGRV1 PKD1L3 ADGRE3	1.05e-03	36	104	3	PS50221
Domain	Cl-channel_core	CLCNKA CLCNKB	1.08e-03	9	104	2	IPR014743
Domain	-	CLCNKA CLCNKB	1.08e-03	9	104	2	1.10.3080.10
Domain	Voltage_CLC	CLCNKA CLCNKB	1.08e-03	9	104	2	PF00654
Domain	Cl-channel_volt-gated	CLCNKA CLCNKB	1.08e-03	9	104	2	IPR001807
Domain	GPS	ADGRV1 PKD1L3 ADGRE3	1.14e-03	37	104	3	IPR000203
Domain	SH3	MAPK8IP1 NEB ITK ASAP2 SRGAP1 PLCG1	1.32e-03	216	104	6	SM00326
Domain	SH3	MAPK8IP1 NEB ITK ASAP2 SRGAP1 PLCG1	1.32e-03	216	104	6	PS50002
Domain	SH3_domain	MAPK8IP1 NEB ITK ASAP2 SRGAP1 PLCG1	1.45e-03	220	104	6	IPR001452
Domain	Ig-like_fold	FLNC DCC LRRC4 PTPRB VCAN CNTN5 IGKC HCFC2 USH2A PLXNA1 EPHA8	1.91e-03	706	104	11	IPR013783
Domain	ASX_HYDROXYL	HEG1 NRXN3 ADGRE3 VCAN	2.36e-03	100	104	4	PS00010
Domain	SEA	MUC16 MUC3A	2.68e-03	14	104	2	SM00200
Domain	EGF-type_Asp/Asn_hydroxyl_site	HEG1 NRXN3 ADGRE3 VCAN	2.92e-03	106	104	4	IPR000152
Domain	CBS	CLCNKA CLCNKB	3.50e-03	16	104	2	SM00116
Domain	-	FLNC DCC LRRC4 PTPRB VCAN CNTN5 HCFC2 USH2A PLXNA1 EPHA8	3.87e-03	663	104	10	2.60.40.10
Domain	EGF_CA	TENM2 HEG1 ADGRE3 VCAN	4.82e-03	122	104	4	SM00179
Domain	EGF-like_Ca-bd_dom	TENM2 HEG1 ADGRE3 VCAN	5.11e-03	124	104	4	IPR001881
Domain	CBS_dom	CLCNKA CLCNKB	5.47e-03	20	104	2	IPR000644
Domain	CBS	CLCNKA CLCNKB	5.47e-03	20	104	2	PF00571
Domain	CBS	CLCNKA CLCNKB	5.47e-03	20	104	2	PS51371
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TMEM94 PUM2 SPATA2 DNAJC6 TENM2 EPG5 STARD9 PCDH19 NAV3 DYNC1H1 DOP1B	5.59e-08	407	107	11	12693553
Pubmed	Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation.	CYBB NLRP3 TRPV2	6.10e-06	12	107	3	25959047
Pubmed	Genomic structure and promoter analysis of the mouse neutral ceramidase gene.	ASAH2 ASAH2B	9.38e-06	2	107	2	12435403
Pubmed	The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.	CLCNKA CLCNKB	9.38e-06	2	107	2	27335120
Pubmed	Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization.	CLCNKA CLCNKB	9.38e-06	2	107	2	8812470
Pubmed	Human placenta secretes apolipoprotein B-100-containing lipoproteins.	APOB MTTP	9.38e-06	2	107	2	15504742
Pubmed	Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney.	ASAH2 ASAH2B	9.38e-06	2	107	2	11328816
Pubmed	Associations between CLCNKA_B tag SNPs with essential hypertension and interactions between genetic and environmental factors in an island population in China.	CLCNKA CLCNKB	9.38e-06	2	107	2	25919862
Pubmed	Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.	ASAH2 ASAH2B	9.38e-06	2	107	2	19345744
Pubmed	Lactosylceramide contributes to mitochondrial dysfunction in diabetes.	ASAH2 ASAH2B	9.38e-06	2	107	2	26900161
Pubmed	A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease.	ASAH2 ASAH2B	9.38e-06	2	107	2	17334805
Pubmed	Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death.	ASAH2 ASAH2B	9.38e-06	2	107	2	26747710
Pubmed	Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells.	APOB MTTP	9.38e-06	2	107	2	15795421
Pubmed	Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.	CLCNKA CLCNKB	9.38e-06	2	107	2	38069401
Pubmed	Angiogenesis-related gene mutations drive a subset of angiosarcomas.	PTPRB PLCG1	9.38e-06	2	107	2	24795022
Pubmed	A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion.	APOB MTTP	9.38e-06	2	107	2	10713055
Pubmed	Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral/alkaline ceramidases.	ASAH2 ASAH2B	9.38e-06	2	107	2	10753931
Pubmed	Identification of mammalian orthologs associates PYPAF5 with distinct functional roles.	NLRP3 NLRP6	9.38e-06	2	107	2	12633874
Pubmed	A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.	CLCNKA CLCNKB	9.38e-06	2	107	2	20805576
Pubmed	Candida albicans SC5314 inhibits NLRP3/NLRP6 inflammasome expression and dampens human intestinal barrier activity in Caco-2 cell monolayer model.	NLRP3 NLRP6	9.38e-06	2	107	2	31629100
Pubmed	NLRP3 and NLRP6 expression in pterygium and normal conjunctiva and their relationship with pterygium formation and recurrence.	NLRP3 NLRP6	9.38e-06	2	107	2	35068231
Pubmed	Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.	APOB MTTP	9.38e-06	2	107	2	24842304
Pubmed	Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.	ASAH2 ASAH2B	9.38e-06	2	107	2	16380386
Pubmed	Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells.	APOB MTTP	9.38e-06	2	107	2	11358959
Pubmed	Salt wasting and deafness resulting from mutations in two chloride channels.	CLCNKA CLCNKB	9.38e-06	2	107	2	15044642
Pubmed	Two highly homologous members of the ClC chloride channel family in both rat and human kidney.	CLCNKA CLCNKB	9.38e-06	2	107	2	8041726
Pubmed	A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.	CLCNKA CLCNKB	9.38e-06	2	107	2	18648499
Pubmed	Disease expression in Usher syndrome caused by VLGR1 gene mutation (USH2C) and comparison with USH2A phenotype.	ADGRV1 USH2A	9.38e-06	2	107	2	15671307
Pubmed	Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.	ASAH2 ASAH2B	9.38e-06	2	107	2	10652340
Pubmed	Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney.	CLCNKA CLCNKB	9.38e-06	2	107	2	8544406
Pubmed	Characteristics of Retinitis Pigmentosa Associated with ADGRV1 and Comparison with USH2A in Patients from a Multicentric Usher Syndrome Study Treatrush.	ADGRV1 USH2A	9.38e-06	2	107	2	34638692
Pubmed	Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.	ASAH2 ASAH2B	9.38e-06	2	107	2	14557071
Pubmed	Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects.	APOB MTTP	9.38e-06	2	107	2	27487388
Pubmed	Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia.	APOB MTTP	9.38e-06	2	107	2	19056372
Pubmed	Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes.	NLRP3 NLRP6	9.38e-06	2	107	2	22503597
Pubmed	Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection.	ASAH2 ASAH2B	9.38e-06	2	107	2	35354041
Pubmed	Identification of novel loci for bipolar I disorder in a multi-stage genome-wide association study.	NRXN3 KAT6B	9.38e-06	2	107	2	24444492
Pubmed	Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.	ASAH2 ASAH2B	9.38e-06	2	107	2	16126722
Pubmed	Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.	CLCNKA CLCNKB	9.38e-06	2	107	2	24863058
Pubmed	Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.	CLCNKA CLCNKB	9.38e-06	2	107	2	9916798
Pubmed	Kidney kinetics and chloride ion pumps.	CLCNKA CLCNKB	9.38e-06	2	107	2	9916791
Pubmed	Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation.	ADGRV1 USH2A	9.38e-06	2	107	2	28653555
Pubmed	Relationship between Amphipathic β Structures in the β1 Domain of Apolipoprotein B and the Properties of the Secreted Lipoprotein Particles in McA-RH7777 Cells.	APOB MTTP	9.38e-06	2	107	2	28702990
Pubmed	Recurrent PTPRB and PLCG1 mutations in angiosarcoma.	PTPRB PLCG1	9.38e-06	2	107	2	24633157
Pubmed	Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.	ASAH2 ASAH2B	9.38e-06	2	107	2	22940715
Pubmed	Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.	ASAH2 ASAH2B	9.38e-06	2	107	2	24659784
Pubmed	NADPH Oxidase 2 Regulates NLRP3 Inflammasome Activation in the Brain after Traumatic Brain Injury.	CYBB NLRP3	9.38e-06	2	107	2	28785377
Pubmed	A common binding site on the microsomal triglyceride transfer protein for apolipoprotein B and protein disulfide isomerase.	APOB MTTP	9.38e-06	2	107	2	9915855
Pubmed	Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.	ASAH2 ASAH2B	9.38e-06	2	107	2	21613224
Pubmed	Desiccating stress worsens alkali burn injury by magnifying caspase-8-induced imbalance of NLRP3 and NLRP6.	NLRP3 NLRP6	9.38e-06	2	107	2	28479336
Pubmed	Novel mutations in abetalipoproteinaemia and homozygous familial hypobetalipoproteinaemia.	APOB MTTP	9.38e-06	2	107	2	18027103
Pubmed	Heparanase induces VEGF C and facilitates tumor lymphangiogenesis.	VEGFC HPSE	9.38e-06	2	107	2	18798279
Pubmed	Hypobetalipoproteinemia with an apparently recessive inheritance due to a "de novo" mutation of apolipoprotein B.	APOB MTTP	9.38e-06	2	107	2	14732481
Pubmed	Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.	ASAH2 ASAH2B	9.38e-06	2	107	2	35151662
Pubmed	Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population.	ASAH2 ASAH2B	9.38e-06	2	107	2	37944753
Pubmed	Role of neutral ceramidase in colon cancer.	ASAH2 ASAH2B	9.38e-06	2	107	2	27609772
Pubmed	Microsomal triglyceride transfer protein activity is not required for the initiation of apolipoprotein B-containing lipoprotein assembly in McA-RH7777 cells.	APOB MTTP	9.38e-06	2	107	2	17690102
Pubmed	Cl(-) channels in basolateral TAL membranes XV. Molecular heterogeneity between cortical and medullary channels.	CLCNKA CLCNKB	9.38e-06	2	107	2	11014860
Pubmed	The molecular circuitry regulating the switch between iron deficiency and overload in mice.	ASAH2 ASAH2B	2.81e-05	3	107	2	16418170
Pubmed	Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.	CLCNKA CLCNKB	2.81e-05	3	107	2	26013830
Pubmed	Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome.	CYBB NLRP3	2.81e-05	3	107	2	25589411
Pubmed	Barttin increases surface expression and changes current properties of ClC-K channels.	CLCNKA CLCNKB	2.81e-05	3	107	2	12111250
Pubmed	PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.	ADGRV1 USH2A	2.81e-05	3	107	2	20440071
Pubmed	Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension.	CLCNKA CLCNKB	2.81e-05	3	107	2	17510212
Pubmed	Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.	APOB MTTP	2.81e-05	3	107	2	19026012
Pubmed	Substrate recognition of PLCγ1 via a specific docking surface on Itk.	ITK PLCG1	2.81e-05	3	107	2	23219468
Pubmed	Identification of a functional hepatocyte nuclear factor 4 binding site in the neutral ceramidase promoter.	ASAH2 ASAH2B	2.81e-05	3	107	2	20803549
Pubmed	The proline rich region of the Tec homology domain of ITK regulates its activity.	ITK PLCG1	2.81e-05	3	107	2	12163161
Pubmed	Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition.	APOB MTTP	2.81e-05	3	107	2	18502767
Pubmed	Neutral ceramidase secreted by endothelial cells is released in part associated with caveolin-1.	ASAH2 ASAH2B	2.81e-05	3	107	2	12921776
Pubmed	Activation of NLRP3 inflammasome in alveolar macrophages contributes to mechanical stretch-induced lung inflammation and injury.	CYBB NLRP3	2.81e-05	3	107	2	23436933
Pubmed	Correlation of Expression of CHI3L1 and Nogo-A and their Role in Angiogenesis in Invasive Ductal Breast Carcinoma.	VEGFC RTN4	2.81e-05	3	107	2	31092426
Pubmed	Barttin modulates trafficking and function of ClC-K channels.	CLCNKA CLCNKB	2.81e-05	3	107	2	16849430
Pubmed	Aberrant expression of NLRP3, NLRC4 and NLRP6 inflammasomes in patients with primary immune thrombocytopenia.	NLRP3 NLRP6	2.81e-05	3	107	2	30802690
Pubmed	Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice.	APOB MTTP	2.81e-05	3	107	2	21562077
Pubmed	Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance.	CLCNKA CLCNKB	2.81e-05	3	107	2	18094726
Pubmed	Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Krüppel-like factor, a novel zinc finger repressor.	CLCNKA CLCNKB	2.81e-05	3	107	2	10982849
Pubmed	Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.	APOB MTTP	2.81e-05	3	107	2	17647275
Pubmed	Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.	VEGFC HPSE	2.81e-05	3	107	2	28209511
Pubmed	Non-USH2A mutations in USH2 patients.	ADGRV1 USH2A	2.81e-05	3	107	2	22147658
Pubmed	Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function.	APOB MTTP	2.81e-05	3	107	2	26224785
Pubmed	Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages.	ASAH2 ASAH2B	2.81e-05	3	107	2	38302493
Pubmed	Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage.	FLNC XIRP2	2.81e-05	3	107	2	27206985
Pubmed	Lowering plasma cholesterol levels halts progression of aortic valve disease in mice.	APOB MTTP	2.81e-05	3	107	2	19433756
Pubmed	Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation.	CYBB NLRP3	2.81e-05	3	107	2	21228274
Pubmed	Apolipoprotein B-related gene expression and ultrastructural characteristics of lipoprotein secretion in mouse yolk sac during embryonic development.	APOB MTTP	2.81e-05	3	107	2	10553000
Pubmed	Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.	APOB MTTP	2.81e-05	3	107	2	24586211
Pubmed	A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients.	FLNC XIRP2	2.81e-05	3	107	2	23115302
Pubmed	Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice.	ASAH2 ASAH2B	2.81e-05	3	107	2	18955860
Pubmed	Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion.	APOB MTTP	2.81e-05	3	107	2	38211723
Pubmed	Complex genetic architecture in severe hypobetalipoproteinemia.	APOB MTTP	2.81e-05	3	107	2	29540175
Pubmed	Assignment of the centromere protein H (Cenph) gene to mouse chromosome band 13D1 by in situ hybridization and interspecific backcross analyses.	MAP1B VCAN	2.81e-05	3	107	2	11060445
Pubmed	Targeted next generation sequencing in Italian patients with Usher syndrome: phenotype-genotype correlations.	ADGRV1 USH2A	2.81e-05	3	107	2	29142287
Pubmed	Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.	CLCNKA CLCNKB	2.81e-05	3	107	2	11734858
Pubmed	ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes.	APOB MTTP	2.81e-05	3	107	2	19020660
Pubmed	Hematopoietic lineage cell-specific protein 1 is recruited to the immunological synapse by IL-2-inducible T cell kinase and regulates phospholipase Cgamma1 Microcluster dynamics during T cell spreading.	ITK PLCG1	2.81e-05	3	107	2	19917685
Pubmed	Vascular function during prolonged progression and regression of atherosclerosis in mice.	APOB MTTP	2.81e-05	3	107	2	23307875
Pubmed	The DFNB31 gene product whirlin connects to the Usher protein network in the cochlea and retina by direct association with USH2A and VLGR1.	ADGRV1 USH2A	2.81e-05	3	107	2	16434480
Pubmed	Microsomal triglyceride transfer protein expression during mouse development.	APOB MTTP	2.81e-05	3	107	2	10744773
Pubmed	Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion.	APOB MTTP	2.81e-05	3	107	2	12628954
GeneFamily	Fibronectin type III domain containing\|USH2 complex	ADGRV1 USH2A	9.34e-05	4	72	2	1244
GeneFamily	Fibronectin type III domain containing	DCC PTPRB CNTN5 USH2A EPHA8	4.42e-04	160	72	5	555
GeneFamily	Trace amine receptors	TAAR8 TAAR6	5.53e-04	9	72	2	188
GeneFamily	Chloride voltage-gated channels	CLCNKA CLCNKB	6.89e-04	10	72	2	302
GeneFamily	CD molecules\|Mucins	MUC16 MUC3A	3.13e-03	21	72	2	648
GeneFamily	NLR family	NLRP3 NLRP6	4.42e-03	25	72	2	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP3 NLRP6	4.42e-03	25	72	2	994
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	MAP1B RTN4 ETS2 DCC NEB DNAJC6 TENM2 AHDC1 CASZ1 NRXN3 SRGAP1 VCAN CNTN5 PCDH19 NAV3 DCLK2 RIMS1 HCFC2 PLXNA1 TPD52L1 DOP1B	2.44e-09	1106	105	21	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	VEGFC MAP1B USP24 PUM2 FAM171A1 HEG1 ASAP2 ARHGAP29 AFF1 PAWR KAT6B TASOR DOP1B	4.75e-08	466	105	13	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	VEGFC MAP1B USP24 PUM2 AHDC1 FAM171A1 HEG1 ASAP2 IGF2R NAV3 ARHGAP29 AFF1 AKAP11 PAWR KAT6B TASOR DOP1B	5.19e-08	856	105	17	M4500
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE	PAG1 PDE3A OLFML2B STARD9 TRPV2 ARHGAP29 PAWR	1.39e-05	195	105	7	M45684
Coexpression	GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP	PDE3A MAP1B LRRC4 VCAN IGKC FBXO43 GJC3	1.59e-05	199	105	7	M6395
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	VEGFC USP24 PUM2 AHDC1 HEG1 NAV3 AFF1 KAT6B	2.86e-05	300	105	8	M8702
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	MAP1B PTCH1 RYR3 ITIH5 HEG1 XIRP2 VCAN PCDH19 TRPV2 ARHGAP29	3.63e-05	505	105	10	M39167
Coexpression	GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP	PAG1 ETS2 DNAJC6 AHDC1 SINHCAF ARHGAP29	3.86e-05	155	105	6	M8913
Coexpression	GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN	ETS2 PTCH1 NEB ITIH5 HEG1 VCAN	4.45e-05	159	105	6	M2979
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP	MAP1B OLFML2B ASAP2 VCAN PLCG1 DYNC1H1	4.94e-05	162	105	6	M45037
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HMGL	CYBB PAG1 ETS2 HPSE NLRP3 TRPV2 NAV3 AFF1 ALOX5AP ZC3HAV1	1.10e-04	577	105	10	M39051
Coexpression	TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL	CYBB PLBD1 ETS2 C1orf162 NLRP3 CCNY VCAN	1.10e-04	270	105	7	M41699
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	RASGRF1 ITK RYR3 PLCG1 KAT6B TASOR	1.41e-04	196	105	6	M5381
Coexpression	GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP	RASGRF1 FAM171A1 ASAP2 HCFC2 EXOC7 TPD52L1	1.45e-04	197	105	6	M4434
Coexpression	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP	ADGRV1 PTCH1 NLRP3 AFF1 KAT6B ZC3HAV1	1.49e-04	198	105	6	M5299
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_UP	CCNY EPG5 DCLK2 TASOR DOP1B ZC3HAV1	1.49e-04	198	105	6	M9245
Coexpression	GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN	ASAH2 AHDC1 ARHGAP29 MTTP PLCG1 HCFC2	1.57e-04	200	105	6	M9311
Coexpression	GSE6875_TCONV_VS_FOXP3_KO_TREG_DN	CYBB SRGAP1 AFF1 PLCG1 MGA TPD52L1	1.57e-04	200	105	6	M6802
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN	MUC16 ITK HEG1 ASAP2 PTPRB STARD9 ADGRE3 ARHGAP29 PLXNA1	1.62e-04	491	105	9	MM455
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	MAPK8IP1 FLNC MYO5B OLFML2B DNAJC6 PTPRB ARHGAP29 RIMS1 ZC3HAV1	1.67e-04	493	105	9	M1951
Coexpression	MURARO_PANCREAS_DUCTAL_CELL	CYBB PDE3A MYO5B ETS2 ITIH5 FAM171A1 SINHCAF HEG1 ASAP2 IGF2R SRGAP1 ARHGAP29 PAWR ALOX5AP TPD52L1	1.71e-04	1276	105	15	M39173
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2	MAPK8IP1 FLNC MYO5B OLFML2B DNAJC6 PTPRB ARHGAP29 RIMS1 ZC3HAV1	1.96e-04	504	105	9	MM830
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	FLNC PDE3A OLFML2B MUC16 PTCH1 ITIH5 NRXN3 IGF2R VCAN	3.25e-05	336	101	9	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000	CYBB VEGFC ASAH2 ETS2 FAM171A1 HEG1 ASAP2 PTPRB STARD9 SRGAP1 NAV3 ARHGAP29 PLCG1 ALOX5AP	3.86e-05	831	101	14	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000	CYBB PLBD1 PAG1 RASGRF1 MYO5B HPSE TENM2 RYR3 NRXN3 PTPRB SRGAP1 VCAN PAWR ALOX5AP	4.12e-05	836	101	14	gudmap_developingKidney_e15.5_Podocyte cells_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000	MAP1B ASAH2 DNAJC6 TENM2 RYR3 CCNY ITIH5 PTPRB IGKC TRPV2 PAWR RIMS1 ZC3HAV1	4.49e-05	734	101	13	gudmap_developingLowerUrinaryTract_adult_bladder_1000
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3	CYBB PLBD1 NLRP3 PTPRB ALOX5AP	5.66e-05	86	101	5	GSM538239_100
CoexpressionAtlas	dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_500	CYBB VEGFC ASAH2 ETS2 HEG1 PTPRB NAV3 ARHGAP29	6.09e-05	282	101	8	gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_100	TENM2 RYR3 ITIH5 TRPV2 RIMS1	6.31e-05	88	101	5	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	PLBD1 FLNC MYO5B OLFML2B MUC16 HPSE BNC1 HEG1 VCAN ARHGAP29 AFF1 DIXDC1 KAT6B	1.03e-04	797	101	13	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500	PAG1 PDE3A MAP1B PUM2 CCNY VCAN DIXDC1	1.19e-04	231	101	7	gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500	CYBB VEGFC ASAH2 ETS2 HEG1 PTPRB SRGAP1 NAV3 ARHGAP29	1.63e-04	415	101	9	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500
CoexpressionAtlas	kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000	ETS2 FAM171A1 ASAP2 PTPRB STARD9 ARHGAP29 ZC3HAV1	1.71e-04	245	101	7	gudmap_kidney_adult_GlomCapSys_Tie2_k3_1000
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000	CYBB VEGFC MAP1B ASAH2 ETS2 FAM171A1 HEG1 ASAP2 PTPRB SRGAP1 NAV3 ARHGAP29 ALOX5AP	1.88e-04	847	101	13	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	CYBB VEGFC ASAH2 ETS2 FAM171A1 HEG1 ASAP2 PTPRB NAV3 ALOX5AP	1.95e-04	523	101	10	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000
CoexpressionAtlas	Myeloid Cells, MF.Sbcaps.SLN, CD11b+ CD169+ F4/80-, Lymph Node, avg-2	CYBB PLBD1 ITK ALOX5AP	2.04e-04	61	101	4	GSM854324_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500	TENM2 RYR3 ITIH5 TRPV2 RIMS1	2.24e-04	115	101	5	gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2
CoexpressionAtlas	Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2	CYBB PLBD1 VCAN ALOX5AP	2.46e-04	64	101	4	GSM854322_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000	FLNC PDE3A MAP1B TENM2 RYR3 ITIH5 IGF2R TRPV2 PAWR DIXDC1 RIMS1 ZC3HAV1	2.64e-04	761	101	12	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_1000	PLBD1 MYO5B HPSE ARHGAP29 AFF1 DIXDC1 KAT6B	3.09e-04	270	101	7	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_1000
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3	CYBB PLBD1 HPSE ALOX5AP	3.11e-04	68	101	4	GSM605875_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000	FLNC TENM2 RYR3 ITIH5 TRPV2 RIMS1	3.14e-04	192	101	6	gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k1
CoexpressionAtlas	Myeloid Cells, DC.103+11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103+ F480-, Small Intestine, avg-5	CYBB PLBD1 NLRP3 ALOX5AP	3.29e-04	69	101	4	GSM854232_100
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3	CYBB PLBD1 VCAN ALOX5AP	3.29e-04	69	101	4	GSM605872_100
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3	CYBB PLBD1 HPSE ALOX5AP	3.29e-04	69	101	4	GSM854329_100
CoexpressionAtlas	Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4	CYBB PLBD1 HPSE ALOX5AP	3.67e-04	71	101	4	GSM605868_100
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	PLBD1 MYO5B MUC16 LRRC4 STARD9 SRGAP1 CNTN5 ARHGAP29 AFF1 DIXDC1 KAT6B ZC3HAV1	3.75e-04	791	101	12	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2	CYBB PLBD1 VCAN ALOX5AP	3.87e-04	72	101	4	GSM854320_100
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	FLNC OLFML2B MUC16 PTCH1 ITIH5 BNC1 VCAN TPD52L1	4.11e-04	373	101	8	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2	CYBB PLBD1 NLRP3 ALOX5AP	4.52e-04	75	101	4	GSM854269_100
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	CYBB PLBD1 C1orf162 ALOX5AP	4.52e-04	75	101	4	GSM605826_100
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	CYBB PLBD1 C1orf162 ALOX5AP	4.76e-04	76	101	4	GSM538248_100
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3	CYBB PLBD1 C1orf162 ALOX5AP	4.76e-04	76	101	4	GSM538249_100
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1	CYBB PLBD1 C1orf162 ALOX5AP	5.00e-04	77	101	4	GSM605839_100
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000	CYBB VEGFC ASAH2 ETS2 FAM171A1 HEG1 ASAP2 PTPRB SRGAP1 NAV3 ARHGAP29 ALOX5AP	5.01e-04	817	101	12	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2	CYBB PLBD1 C1orf162 ALOX5AP	5.25e-04	78	101	4	GSM538266_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500	MAP1B NEB DNAJC6 TENM2 RYR3 ITIH5 TRPV2 RIMS1	5.33e-04	388	101	8	gudmap_developingLowerUrinaryTract_P1_bladder_500_J
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	CYBB PLBD1 C1orf162 ALOX5AP	5.51e-04	79	101	4	GSM538265_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_100	TENM2 RYR3 TRPV2	5.62e-04	34	101	3	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k4
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2	CYBB PLBD1 C1orf162 ALOX5AP	5.78e-04	80	101	4	GSM605837_100
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000	MAP1B RASGRF1 TENM2 FAM171A1 DIXDC1	5.90e-04	142	101	5	gudmap_developingKidney_e15.5_1000_k1
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2	CYBB PLBD1 NLRP3 ALOX5AP	6.06e-04	81	101	4	GSM854271_100
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3	CYBB PLBD1 NLRP3 ALOX5AP	6.06e-04	81	101	4	GSM605823_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000	VEGFC PAG1 MAP1B OLFML2B HPSE BNC1 NRXN3 PTPRB SRGAP1 VCAN TRPV2 PAWR	6.20e-04	837	101	12	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000
CoexpressionAtlas	Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	CYBB PLBD1 C1orf162 ALOX5AP	6.35e-04	82	101	4	GSM538242_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	FLNC MUC16 PTCH1 ITIH5 VCAN	6.90e-04	147	101	5	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	PAG1 PUM2 NEB TENM2 BNC1 ASAP2 STARD9 VCAN DIXDC1 RIMS1 HCFC2 KAT6B	7.10e-04	850	101	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#1_top-relative-expression-ranked_1000	TENM2 RYR3 ITIH5 TRPV2 RIMS1	7.12e-04	148	101	5	gudmap_developingLowerUrinaryTract_adult_bladder_1000_k1
CoexpressionAtlas	Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3	CYBB C1orf162 HPSE ALOX5AP	7.27e-04	85	101	4	GSM605843_100
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500	CYBB VEGFC ASAH2 ETS2 HEG1 PTPRB NAV3 ARHGAP29	7.51e-04	409	101	8	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500
CoexpressionAtlas	Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3	CYBB C1orf162 HPSE ALOX5AP	7.59e-04	86	101	4	GSM605840_100
CoexpressionAtlas	Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3	CYBB C1orf162 HPSE ALOX5AP	7.93e-04	87	101	4	GSM854299_100
CoexpressionAtlas	Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2	CYBB C1orf162 HPSE ALOX5AP	7.93e-04	87	101	4	GSM854297_100
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500	VEGFC ASAH2 ETS2 HEG1 PTPRB SRGAP1 NAV3 ARHGAP29	8.13e-04	414	101	8	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500
CoexpressionAtlas	dev gonad_e11.5_M_ReproVasc_Flk_top-relative-expression-ranked_500	VEGFC ASAH2 ETS2 HEG1 PTPRB NAV3 ARHGAP29 ALOX5AP	8.13e-04	414	101	8	gudmap_dev gonad_e11.5_M_ReproVasc_Flk_500
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_500	CYBB VEGFC ASAH2 ETS2 HEG1 PTPRB NAV3 ARHGAP29	8.38e-04	416	101	8	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_500
CoexpressionAtlas	dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	CYBB VEGFC ASAH2 ETS2 HEG1 PTPRB SRGAP1 NAV3 ALOX5AP	8.74e-04	523	101	9	gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k3_1000
CoexpressionAtlas	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K4	PDE3A ADGRV1 NRXN3	9.76e-04	41	101	3	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_1000	RASGRF1 TENM2 RYR3 NRXN3 PAWR	1.01e-03	160	101	5	gudmap_developingKidney_e15.5_Podocyte cells_1000_k3
CoexpressionAtlas	dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500	CYBB VEGFC ASAH2 ETS2 HEG1 PTPRB NAV3 ARHGAP29	1.04e-03	430	101	8	gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_500
CoexpressionAtlas	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K2	MAP1B ADGRV1 NRXN3 PAWR	1.10e-03	95	101	4	facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000	FLNC MAP1B ASAH2 NEB DNAJC6 TENM2 RYR3 ITIH5 TRPV2 PAWR RIMS1	1.11e-03	772	101	11	gudmap_developingLowerUrinaryTract_P1_bladder_1000_J
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#3_top-relative-expression-ranked_500	PLBD1 MYO5B RYR3	1.12e-03	43	101	3	gudmap_developingKidney_e15.5_Podocyte cells_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200	TENM2 RYR3 ITIH5 TRPV2 RIMS1	1.13e-03	164	101	5	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200	MAP1B RYR3 VCAN TRPV2 DIXDC1	1.13e-03	164	101	5	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000	MAP1B ASAH2 DNAJC6 RYR3 CCNY ITIH5 PTPRB TRPV2 PAWR RIMS1 ALOX5AP	1.13e-03	774	101	11	gudmap_developingLowerUrinaryTract_P1_ureter_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000	FLNC MAP1B RTN4 TENM2 CASZ1 RYR3 ITIH5 IGF2R PTPRB TRPV2 RIMS1	1.13e-03	774	101	11	gudmap_developingLowerUrinaryTract_P1_bladder_1000_B
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500	FLNC MUC16 PTCH1 ITIH5 VCAN	1.16e-03	165	101	5	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	CYBB ASAH2 ETS2 FAM171A1 HEG1 ASAP2 PTPRB NAV3	1.27e-03	444	101	8	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000	FLNC TENM2 RYR3 ITIH5 TRPV2 RIMS1	1.28e-03	251	101	6	gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k2
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500	CYBB VEGFC ASAH2 ETS2 PTPRB	1.32e-03	170	101	5	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100	MAP1B ADGRV1 NRXN3 PCDH19	1.33e-03	100	101	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	VEGFC RTN4 PUM2 ADGRV1 PTCH1 LRRC4 PCDH19 DIXDC1 KAT6B MGA TPD52L1	1.35e-03	791	101	11	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DCC TENM2 NRXN3 XIRP2 CNTN5 NAV3 RIMS1 USH2A	4.94e-09	159	107	8	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOB ADGRV1 DCC NEB RYR3 XIRP2 NAV3 USH2A	1.55e-08	184	107	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOB ADGRV1 DCC NEB RYR3 XIRP2 NAV3 USH2A	1.55e-08	184	107	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOB ADGRV1 DCC NEB RYR3 XIRP2 NAV3 USH2A	1.55e-08	184	107	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYBB ETS2 MUC16 ADGRV1 SRGAP1 VCAN CNTN5 USH2A	1.69e-08	186	107	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ETS2 CCNY ITIH5 FAM171A1 HEG1 ASAP2 PTPRB ARHGAP29	2.96e-08	200	107	8	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ETS2 CCNY ITIH5 FAM171A1 HEG1 ASAP2 PTPRB ARHGAP29	2.96e-08	200	107	8	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYBB PLBD1 PAG1 C1orf162 ITIH5 ADGRE3 TRPV2 ALOX5AP	2.96e-08	200	107	8	efdbd1273b07d9fe957380e347b5b6b45db0a271
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYBB PLBD1 PAG1 C1orf162 ITIH5 ADGRE3 TRPV2 ALOX5AP	2.96e-08	200	107	8	9ca86928fceaa1fefd0f9ffcfa5cc0a210ee5792
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	PAG1 PDE3A OLFML2B SRGAP1 VCAN ARHGAP29 PAWR	2.62e-07	179	107	7	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLBD1 RASGRF1 CD207 ETS2 C1orf162 PKD1L3 SRGAP1	2.93e-07	182	107	7	1d37c486173cc4629842893ddd5033987c04086f
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-DC-cDC2-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLBD1 RASGRF1 CD207 ETS2 C1orf162 PKD1L3 SRGAP1	2.93e-07	182	107	7	aef67bdc6937b315522d39959e26c9b0acf7ab52
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-DC\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLBD1 RASGRF1 CD207 ETS2 C1orf162 PKD1L3 SRGAP1	2.93e-07	182	107	7	087c9f88daf08f5d688b728c2386f91f210d2255
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	VEGFC CASZ1 FAM171A1 PTPRB NAV3 ARHGAP29 RIMS1	3.27e-07	185	107	7	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	VEGFC MAP1B ASAP2 PTPRB ARHGAP29 PAWR RIMS1	3.91e-07	190	107	7	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM171A1 NRXN3 PTPRB NAV3 ARHGAP29 DCLK2 RIMS1	4.50e-07	194	107	7	71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM171A1 NRXN3 PTPRB NAV3 ARHGAP29 DCLK2 RIMS1	4.50e-07	194	107	7	68004855b23fe1e31e8452d70effabc78a4a0bd3
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYBB PLBD1 OLFML2B ETS2 C1orf162 NLRP3 VCAN	4.66e-07	195	107	7	403d874198a7bde626b0d0b4efad8dbb34060761
ToppCell	severe_COVID-19-Non-classical_Monocyte\|World / disease group, cell group and cell class (v2)	CYBB PAG1 OLFML2B ETS2 C1orf162 SRGAP1 ARHGAP29	4.66e-07	195	107	7	72928a1d987a3a5361c666f3972292aefec5f548
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VEGFC PDE3A FAM171A1 HEG1 PTPRB NAV3 ARHGAP29	4.66e-07	195	107	7	023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB PLBD1 ETS2 C1orf162 NLRP3 VCAN ALOX5AP	5.35e-07	199	107	7	571accef38f5b03a7e032495d5c6d25d27073428
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ETS2 FAM171A1 HEG1 ASAP2 PTPRB ARHGAP29 DYNC1H1	5.53e-07	200	107	7	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Transverse-Macrophage-Macrophage\|Transverse / Region, Cell class and subclass	CYBB PLBD1 OLFML2B ETS2 C1orf162 NLRP3 VCAN	5.53e-07	200	107	7	17548806ba38008050244151d1216c69ef8a8310
ToppCell	Transverse-(6)_Macrophage\|Transverse / shred on region, Cell_type, and subtype	CYBB PLBD1 OLFML2B ETS2 C1orf162 NLRP3 VCAN	5.53e-07	200	107	7	b28350de555fa756d2631f004f71d5ac69b1affe
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB PLBD1 OLFML2B C1orf162 NLRP3 VCAN ALOX5AP	5.53e-07	200	107	7	26df6ac63710655604888c3be6509b6c4befc0be
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ETS2 FAM171A1 HEG1 ASAP2 PTPRB ARHGAP29 DYNC1H1	5.53e-07	200	107	7	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5B MUC16 ADGRV1 CASZ1 SRGAP1 TPD52L1 DOP1B	5.53e-07	200	107	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Transverse-Macrophage\|Transverse / Region, Cell class and subclass	CYBB PLBD1 OLFML2B ETS2 C1orf162 NLRP3 VCAN	5.53e-07	200	107	7	1920605e5811938814d02b971069a4506868db5f
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ETS2 FAM171A1 HEG1 ASAP2 PTPRB ARHGAP29 DCLK2	5.53e-07	200	107	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	Lung_Parenchyma-Control\|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLBD1 PAG1 RTN4 ETS2 C1orf162 TRPV2 ALOX5AP	5.53e-07	200	107	7	2cb0fba2477d885b62850e473b4b637a5af531a9
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ETS2 CCNY ITIH5 FAM171A1 ASAP2 PTPRB ARHGAP29	5.53e-07	200	107	7	58a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCell	Transverse-(6)_Macrophage-(60)_Macrophage\|Transverse / shred on region, Cell_type, and subtype	CYBB PLBD1 OLFML2B ETS2 C1orf162 NLRP3 VCAN	5.53e-07	200	107	7	2be675684a2958ea609939bb45248bede78a26bc
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5B MUC16 ADGRV1 CASZ1 SRGAP1 TPD52L1 DOP1B	5.53e-07	200	107	7	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB PLBD1 OLFML2B C1orf162 NLRP3 VCAN ALOX5AP	5.53e-07	200	107	7	07819a90ac347883b78d0bb3cd8c5eb0d66e1e22
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	MUC16 DCC NRXN3 PTPRB CNTN5 USH2A	1.09e-06	139	107	6	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	facs-Lung-Endomucin-24m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 HPSE NRXN3 VCAN ALOX5AP	1.91e-06	153	107	6	9c3220604b7fa4d91577b6c46960960f49644ca1
ToppCell	facs-Lung-Endomucin-24m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 HPSE NRXN3 VCAN ALOX5AP	1.91e-06	153	107	6	ba624782693b0daa642e50881dbf5f0663fea82d
ToppCell	droplet-Mammary_Gland-nan-3m-Myeloid\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 CD207 C1orf162 NLRP3 ALOX5AP	1.98e-06	154	107	6	12d3ecb0c4d814a91ac833fcb74db6b9dbc0a321
ToppCell	droplet-Mammary_Gland-nan-3m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 CD207 C1orf162 NLRP3 ALOX5AP	1.98e-06	154	107	6	64192a0f78021551886bbaf929916392bce451c0
ToppCell	droplet-Mammary_Gland-nan-3m-Myeloid-macrophage\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 CD207 C1orf162 NLRP3 ALOX5AP	1.98e-06	154	107	6	93ace0a42f3ea94605b13acd79659602b3a31b74
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VEGFC PDE3A FAM171A1 PTPRB NAV3 ARHGAP29	2.22e-06	157	107	6	275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8
ToppCell	facs-Lung-24m-Hematologic-myeloid-classical_monocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB PLBD1 C1orf162 HPSE VCAN ALOX5AP	3.76e-06	172	107	6	f557ec1b4d08b42559da02dd1f2387283c6380a2
ToppCell	ILEUM-non-inflamed-(3)_Inf._Macrophages\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CYBB PLBD1 C1orf162 PKD1L3 NLRP3 VCAN	3.88e-06	173	107	6	a8db746992a915a8431ac5c155612e89c4af3cad
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Intermediate_macrophages\|bone_marrow / Manually curated celltypes from each tissue	CYBB OLFML2B ETS2 NLRP3 SRGAP1 VCAN	4.01e-06	174	107	6	268abfc4d53a3ba3931dbcafffef09a72ea0edfa
ToppCell	Bronchial_Biopsy-Epithelial-Ionocytes\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	APOB ITIH5 CLCNKA CLCNKB NAV3 GJC3	4.01e-06	174	107	6	7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb
ToppCell	Bronchial_Biopsy-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	APOB ITIH5 CLCNKA CLCNKB NAV3 GJC3	4.15e-06	175	107	6	13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLBD1 CD207 ETS2 C1orf162 NLRP3 ADGRE3	4.29e-06	176	107	6	a31d7532f8c055d4e62bbaa78d819f2495bfee00
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B ASAH2 HPSE PTPRB MGA TASOR	4.72e-06	179	107	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 ADGRV1 CASZ1 SRGAP1 PAWR RIMS1	4.72e-06	179	107	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	metastatic_Brain-Myeloid_cells-Pleural_Mac\|metastatic_Brain / Location, Cell class and cell subclass	CYBB PLBD1 CLCA4 C1orf162 VCAN ALOX5AP	4.88e-06	180	107	6	7de1c8ab1152fa517c6b4830d93ff53a19fca3d7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 ITIH5 VCAN NAV3 ARHGAP29 PAWR	5.03e-06	181	107	6	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 ITIH5 VCAN NAV3 ARHGAP29 PAWR	5.03e-06	181	107	6	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	USP24 FAM171A1 ASAP2 CLCNKA CLCNKB TPD52L1	5.36e-06	183	107	6	2e831a4d99c6f983793df71c0994124c943c6da9
ToppCell	COPD-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	FLNC MAP1B MUC16 BNC1 HEG1 PAWR	5.71e-06	185	107	6	23579988036fc1925992c31919750f9b3fe9f790
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VEGFC PDE3A FAM171A1 HEG1 PTPRB ARHGAP29	5.71e-06	185	107	6	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	VEGFC PDE3A RYR3 FAM171A1 HEG1 PTPRB	5.89e-06	186	107	6	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	PAG1 USP24 EPG5 IGF2R DYNC1H1 ZC3HAV1	6.26e-06	188	107	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	P28-Endothelial-large_vessel_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VEGFC PDE3A MAP1B HEG1 PTPRB ALOX5AP	6.26e-06	188	107	6	263169029293e005bcffd87db20221fdd2d3917e
ToppCell	wk_08-11-Epithelial-PNS-intermediate_Schwann\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	OLFML2B LRRC4 ITIH5 NRXN3 GJC3 TSC22D4	6.26e-06	188	107	6	3f3a744b2615bf72f6119f26087099110c0d21fc
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	FLNC MAP1B MUC16 BNC1 HEG1 PAWR	6.45e-06	189	107	6	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBB PAG1 ITIH5 ADGRE3 TRPV2 ALOX5AP	6.45e-06	189	107	6	a59025e82fabd9d60e2438dee85b2644478cc7c8
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	VEGFC PDE3A FAM171A1 HEG1 PTPRB ARHGAP29	6.45e-06	189	107	6	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB PLBD1 ETS2 C1orf162 NLRP3 VCAN	6.65e-06	190	107	6	6cf9a41c1a0fa1ce6a8711caa7c71ff6b55df9e1
ToppCell	(2)_Dendritic_Cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CYBB OLFML2B CD207 C1orf162 NLRP3 ALOX5AP	6.65e-06	190	107	6	5163a5be95fb6c2609bfa3d69166af172f74e724
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VEGFC PDE3A FAM171A1 HEG1 PTPRB ARHGAP29	6.65e-06	190	107	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	PSB-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ITIH5 CLCNKA CLCNKB PCDH19 NAV3 DCLK2	6.85e-06	191	107	6	8f4637e801554e2343b974fe7794f01dd2151418
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VEGFC PDE3A FAM171A1 HEG1 PTPRB ARHGAP29	6.85e-06	191	107	6	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VEGFC FAM171A1 HEG1 ASAP2 NRXN3 PTPRB	6.85e-06	191	107	6	fcdf3a747038e346a467eae8b7c293592658b53f
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	OLFML2B DNAJC6 ITIH5 BNC1 NRXN3 PAWR	6.85e-06	191	107	6	4c4eb61e6179d2f8fc524d2f813db9cba84f67a2
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBB PLBD1 C1orf162 HPSE NLRP3 VCAN	6.85e-06	191	107	6	5d6ef70cc15ec5e983a953e547e40f9c06e355fb
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CYBB PLBD1 ETS2 C1orf162 NLRP3 VCAN	6.85e-06	191	107	6	63d4226a8b59f648bdc9f41e4b2d750dfa342034
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VEGFC RYR3 HEG1 PTPRB ARHGAP29 TPD52L1	7.06e-06	192	107	6	eafead22bba48ac5ee568faa8946c444445c1034
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC OLFML2B ITIH5 HEG1 SRGAP1 VCAN	7.06e-06	192	107	6	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PAG1 PDE3A OLFML2B TRPV2 ARHGAP29 PAWR	7.06e-06	192	107	6	55f95454399fd533df75db06584eaa48d6ee3830
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBB PLBD1 C1orf162 ITIH5 TRPV2 ALOX5AP	7.06e-06	192	107	6	fb0d05a2c83816794652a6e5af8713e9bb22d5db
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A FAM171A1 HEG1 ASAP2 PTPRB ARHGAP29	7.06e-06	192	107	6	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PAG1 PDE3A OLFML2B TRPV2 ARHGAP29 PAWR	7.06e-06	192	107	6	5000440dc1ed17e7474d340921bdff945646f27e
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VEGFC FAM171A1 HEG1 ASAP2 NRXN3 PTPRB	7.06e-06	192	107	6	cd4c9b9ab17a779c154264f7459020f51e528ba5
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ITIH5 PTPRB ARHGAP29 PAWR GJC3 TPD52L1	7.27e-06	193	107	6	3f8280ef849d95b2fcea5e6824b95a07febc96d0
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 HEG1 ASAP2 PTPRB ARHGAP29 DCLK2	7.27e-06	193	107	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	Macrophages-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	PLBD1 C1orf162 ITIH5 ADGRE3 TRPV2 ALOX5AP	7.27e-06	193	107	6	18534bd60bdd1ce51f948380c78017679931b8b1
ToppCell	(2)_MNPs\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	CYBB CD207 C1orf162 NLRP3 VCAN ALOX5AP	7.49e-06	194	107	6	9cd64e325ec233da82c463b09262efe93d2a92ee
ToppCell	medial-2-Hematologic-EREG+_Dendritic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OLFML2B C1orf162 NEB HPSE NLRP3 VCAN	7.49e-06	194	107	6	b2b4e4c3ac0df0d9f17b930ffb60c0fd85b3dd78
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CYBB PLBD1 C1orf162 IGF2R ADGRE3 VCAN	7.49e-06	194	107	6	e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCell	medial-Hematologic-EREG+_Dendritic-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OLFML2B C1orf162 NEB HPSE NLRP3 VCAN	7.49e-06	194	107	6	15f3b6b6579e388d0820f05e93a77ee1634bd6c3
ToppCell	normal_Lung\|World / Location, Cell class and cell subclass	CYBB PLBD1 RTN4 C1orf162 TRPV2 ALOX5AP	7.49e-06	194	107	6	affae83d7f982d18117f5b95705f09809f304b0b
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLBD1 C1orf162 ITIH5 ADGRE3 TRPV2 ALOX5AP	7.49e-06	194	107	6	412c2b8eb522da6c84f8b00d32d6f0bee555251f
ToppCell	kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYBB OLFML2B C1orf162 NLRP3 SRGAP1 ALOX5AP	7.49e-06	194	107	6	abce1e824ce2512741c313a5ec336d12f580b093
ToppCell	medial-Hematologic-EREG+_Dendritic\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OLFML2B C1orf162 NEB HPSE NLRP3 VCAN	7.49e-06	194	107	6	1f3d22292d2691f93aa7b6770f5c250a33db3cc0
ToppCell	kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYBB OLFML2B C1orf162 NLRP3 SRGAP1 ALOX5AP	7.49e-06	194	107	6	6810586080cc893e3270b9c8bee2d95ed78e2893
ToppCell	11.5-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	PAG1 PDE3A OLFML2B TRPV2 ARHGAP29 PAWR	7.49e-06	194	107	6	08701590496cf85ff790e54a81493c61177e76ff
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VEGFC ETS2 RYR3 FAM171A1 PTPRB ARHGAP29	7.71e-06	195	107	6	fde8e7b38b3631109b95ef111c5f6e3f9878cfbd
ToppCell	NS-critical-d_07-13-Myeloid-Non-resident_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CYBB OLFML2B C1orf162 NLRP3 VCAN TRPV2	7.71e-06	195	107	6	ee8743d39996bb756f50db32748e8a902d3294b8
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYBB PLBD1 ETS2 C1orf162 NLRP3 VCAN	7.71e-06	195	107	6	580ed65b4152483b642a7e7dbdf00d03588c46f6
ToppCell	severe-Classical_Monocyte\|World / disease stage, cell group and cell class	CYBB PLBD1 ETS2 C1orf162 NLRP3 VCAN	7.71e-06	195	107	6	cf638aac4d57ae0774008920a1a5e9dfd8c73885
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBB OLFML2B CD207 C1orf162 NLRP3 SRGAP1	7.71e-06	195	107	6	f289a44010788853d7726d4b5aa75f3c62186c08
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC CCNY ITIH5 FAM171A1 HEG1 PTPRB	7.71e-06	195	107	6	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VEGFC ETS2 FAM171A1 HEG1 PTPRB ARHGAP29	7.71e-06	195	107	6	81a98ebb0d43f416f9a8bba580531dc0cfea8f74
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	MAP1B ASAH2 ETS2 FAM171A1 SRGAP1 ARHGAP29	7.71e-06	195	107	6	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC ETS2 RYR3 HEG1 PTPRB STARD9	7.94e-06	196	107	6	8ad8efb631164b46f0c082572270188e5ead20bf
Computational	Neighborhood of FOS	CYBB PLBD1 NLRP3 VCAN	1.04e-04	41	65	4	GNF2_FOS
Computational	Neighborhood of CD33	CYBB PLBD1 NLRP3 VCAN	2.65e-04	52	65	4	GNF2_CD33
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; HL60; HT_HG-U133A	VEGFC MAP1B VCAN PLCG1 TSC22D4 SLC24A1 PLXNA1 TPD52L1 ZC3HAV1	3.05e-07	195	105	9	2460_DN
Disease	Bartter disease type 4B	CLCNKA CLCNKB	1.28e-05	2	106	2	cv:C4310805
Disease	Bartter disease type 3 (implicated_via_orthology)	CLCNKA CLCNKB	1.28e-05	2	106	2	DOID:0110144 (implicated_via_orthology)
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	1.28e-05	2	106	2	613090
Disease	BARTTER SYNDROME, TYPE 4B	CLCNKA CLCNKB	1.28e-05	2	106	2	C2751312
Disease	BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	CLCNKA CLCNKB	1.28e-05	2	106	2	C4310805
Disease	Bartter disease type 4b (is_implicated_in)	CLCNKA CLCNKB	1.28e-05	2	106	2	DOID:0110146 (is_implicated_in)
Disease	Bartter disease (implicated_via_orthology)	CLCNKA CLCNKB	1.28e-05	2	106	2	DOID:445 (implicated_via_orthology)
Disease	sleep duration, low density lipoprotein cholesterol measurement	USP24 APOB PKD1L3 IGF2R PLCG1	1.98e-05	91	106	5	EFO_0004611, EFO_0005271
Disease	Hemangiosarcoma	VEGFC PTPRB PLCG1	3.54e-05	18	106	3	C0018923
Disease	triglyceride measurement, intermediate density lipoprotein measurement	APOB IGF2R MTTP AFF1 ASAH2B	5.15e-05	111	106	5	EFO_0004530, EFO_0008595
Disease	glycoprotein measurement	APOB ADGRV1 PKD1L3 NLRP3 PLCG1	7.18e-05	119	106	5	EFO_0004555
Disease	Disorder of eye	ADGRV1 VCAN MTTP RIMS1 SLC24A1 USH2A	1.20e-04	212	106	6	C0015397
Disease	apolipoprotein B measurement	USP24 PUM2 APOB PKD1L3 CASZ1 IGF2R MTTP AFF1 PLCG1 ASAH2B	1.41e-04	663	106	10	EFO_0004615
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	APOB IGF2R MTTP AFF1 PLCG1 ASAH2B	1.47e-04	220	106	6	EFO_0004529, EFO_0008317
Disease	quality of life during menstruation measurement, breast pressure measurement	MAP1B DCLK2	1.90e-04	6	106	2	EFO_0009366, EFO_0009393
Disease	Bartter syndrome	CLCNKA CLCNKB	1.90e-04	6	106	2	cv:C0004775
Disease	unipolar depression, bipolar disorder	VEGFC DCC TENM2 STARD9 CNTN5	2.55e-04	156	106	5	EFO_0003761, MONDO_0004985
Disease	LDL cholesterol change measurement	APOB PKD1L3	2.65e-04	7	106	2	EFO_0007804
Disease	cholesteryl esters to total lipids in medium LDL percentage	APOB IGF2R AFF1	3.20e-04	37	106	3	EFO_0022252
Disease	underweight body mass index status	DCC NRXN3	4.53e-04	9	106	2	EFO_0005936
Disease	isovalerate measurement	FAM171A1 USH2A	4.53e-04	9	106	2	EFO_0021051
Disease	gastroesophageal reflux disease	APOB DCC VCAN NAV3	4.92e-04	101	106	4	EFO_0003948
Disease	Proteinuria	CYBB MUC16 ALOX5AP	5.01e-04	43	106	3	C0033687
Disease	triglycerides in large LDL measurement	APOB IGF2R AFF1	5.01e-04	43	106	3	EFO_0022319
Disease	cognitive impairment measurement	CD207 NAV3 DCLK2	5.36e-04	44	106	3	EFO_0007998
Disease	nephrogenic diabetes insipidus (implicated_via_orthology)	CLCNKA CLCNKB	5.65e-04	10	106	2	DOID:12387 (implicated_via_orthology)
Disease	familial hypercholesterolemia (is_implicated_in)	APOB MTTP	5.65e-04	10	106	2	DOID:13810 (is_implicated_in)
Disease	familial hyperlipidemia	APOB IGF2R AFF1 ASAH2B	5.90e-04	106	106	4	MONDO_0001336
Disease	brain connectivity measurement	RTN4 ADGRV1 PTCH1 VCAN NAV3 AFF1 DCLK2	6.16e-04	400	106	7	EFO_0005210
Disease	Bipolar I disorder	NRXN3 KAT6B	6.88e-04	11	106	2	C0853193
Disease	glycerophosphorylcholine measurement	DCLK2 EPHA8	6.88e-04	11	106	2	EFO_0020018
Disease	hippocampal CA1 volume	PTCH1 VCAN DCLK2	6.93e-04	48	106	3	EFO_0009394
Disease	myopathy (implicated_via_orthology)	FLNC CLCNKA CLCNKB	6.93e-04	48	106	3	DOID:423 (implicated_via_orthology)
Disease	pathological myopia	PAG1 TRHR CNTN5 NAV3	7.01e-04	111	106	4	EFO_0004207
Disease	cholesterol in small VLDL measurement	APOB IGF2R AFF1	9.26e-04	53	106	3	EFO_0022228
Disease	total lipids in medium VLDL	APOB IGF2R AFF1	9.78e-04	54	106	3	EFO_0022153
Disease	response to TNF antagonist	PDE3A PKD1L3 RIMS1	9.78e-04	54	106	3	EFO_0004653
Disease	triglycerides in LDL measurement	APOB IGF2R AFF1	1.09e-03	56	106	3	EFO_0022320
Disease	thyroid stimulating hormone measurement	VEGFC TRHR NEB FAM171A1 NRXN3 CLCNKA	1.12e-03	323	106	6	EFO_0004748
Disease	triglycerides in IDL measurement	APOB IGF2R AFF1	1.20e-03	58	106	3	EFO_0022149
Disease	coronary artery disease	MAP1B APOB PKD1L3 SPATA2 AHDC1 EPG5 SINHCAF ASAP2 IGF2R PAWR DCLK2 PLCG1	1.21e-03	1194	106	12	EFO_0001645
Disease	fibroblast growth factor basic measurement	MAP1B NRXN3 NAV3	1.27e-03	59	106	3	EFO_0008130
Disease	phospholipids in VLDL measurement	APOB IGF2R AFF1	1.27e-03	59	106	3	EFO_0022301
Disease	hepcidin:transferrin saturation ratio	MUC16 NLRP6	1.30e-03	15	106	2	EFO_0007902
Disease	amenorrhea, response to antineoplastic agent	APOB RIMS1	1.30e-03	15	106	2	EFO_0010269, GO_0097327
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	APOB IGF2R MTTP AFF1 ASAH2B	1.31e-03	224	106	5	EFO_0004530, EFO_0008317
Disease	total lipids in VLDL measurement	APOB IGF2R AFF1	1.33e-03	60	106	3	EFO_0022314
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	PDE3A USP24 APOB IGF2R AFF1	1.34e-03	225	106	5	EFO_0008317, EFO_0020947
Disease	free cholesterol in VLDL measurement	APOB IGF2R AFF1	1.39e-03	61	106	3	EFO_0022276
Disease	triglycerides in medium LDL measurement	APOB IGF2R AFF1	1.46e-03	62	106	3	EFO_0022322
Disease	Schizoaffective disorder-bipolar type	PTCH1 NRXN3	1.48e-03	16	106	2	EFO_0009965
Disease	phosphatidylcholine 38:3 measurement	IGF2R ALOX5AP	1.48e-03	16	106	2	EFO_0010385
Disease	cholangiocarcinoma (is_marker_for)	MUC16 PAWR MUC3A	1.60e-03	64	106	3	DOID:4947 (is_marker_for)
Disease	cholesterol in large VLDL measurement	APOB IGF2R AFF1	1.67e-03	65	106	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	APOB IGF2R AFF1	1.67e-03	65	106	3	EFO_0022230
Disease	hair colour measurement	PUM2 ADGRV1 PKD1L3 CCNY EPG5 BNC1 PAWR PLXNA1	1.72e-03	615	106	8	EFO_0007822
Disease	total lipids in small VLDL	APOB IGF2R AFF1	1.83e-03	67	106	3	EFO_0022148
Disease	triglycerides in very small VLDL measurement	APOB IGF2R AFF1	1.91e-03	68	106	3	EFO_0022144
Disease	rosacea severity measurement	MRPS22 NRXN3 DCLK2 RIMS1	1.98e-03	147	106	4	EFO_0009180
Disease	Manic Disorder	STARD9 DIXDC1 RIMS1	2.16e-03	71	106	3	C0024713
Disease	pentachlorophenol measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022071
Disease	parathion measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022070
Disease	potassium chromate measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022072
Disease	mercuric chloride measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022068
Disease	heptachlor epoxide measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022067
Disease	methoxychlor measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022052
Disease	azinphos methyl measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022055
Disease	aldrin measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022054
Disease	dicofol measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022060
Disease	disulfoton measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022062
Disease	dieldrin measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022061
Disease	endrin measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022064
Disease	endosulfan measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022063
Disease	heptachlor measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022066
Disease	ethion measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022065
Disease	chlorpyrifos measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022057
Disease	cadmium chloride measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022056
Disease	diazinon measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022059
Disease	dibutyl phthalate measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0022058
Disease	environmental exposure measurement	MUC16 NLRP3 USH2A	2.33e-03	73	106	3	EFO_0008360
Disease	DDT metabolite measurement	MUC16 NLRP3 USH2A	2.43e-03	74	106	3	EFO_0007886
Disease	lean body mass	PDE3A TRHR ADGRV1 PTCH1 VCAN TASOR	2.51e-03	379	106	6	EFO_0004995
Disease	very low density lipoprotein cholesterol measurement	APOB IGF2R CNTN5 AFF1 ASAH2B	2.51e-03	260	106	5	EFO_0008317
Disease	proprotein convertase subtilisin/kexin type 9 measurement	USP24 APOB	2.82e-03	22	106	2	EFO_0009312
Disease	Manic	STARD9 DIXDC1 RIMS1	2.82e-03	78	106	3	C0338831
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	APOB IGF2R AFF1	2.82e-03	78	106	3	EFO_0022187
Disease	Depression, Bipolar	STARD9 DIXDC1 RIMS1	2.92e-03	79	106	3	C0005587
Disease	pulmonary hypertension (biomarker_via_orthology)	CYBB PDE3A RYR3	3.03e-03	80	106	3	DOID:6432 (biomarker_via_orthology)
Disease	smoking status measurement	DCC TENM2 ZNF518A BNC1 FANCF DEFB112 NRXN3 CNTN5 DIXDC1 RIMS1 USH2A	3.04e-03	1160	106	11	EFO_0006527
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	APOB IGF2R AFF1 ASAH2B	3.07e-03	166	106	4	EFO_0004530, EFO_0004611
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	APOB IGF2R MTTP AFF1 ASAH2B	3.15e-03	274	106	5	EFO_0004530, EFO_0004612
Disease	trans fatty acid measurement, trans/trans-18:2 fatty acid measurement	RYR3 CNTN5	3.35e-03	24	106	2	EFO_0006821, EFO_0006826
Disease	trauma exposure measurement	DCC TENM2 NRXN3 SRGAP1	3.49e-03	172	106	4	EFO_0010703
Disease	apolipoprotein A 1 measurement	PDE3A MYO5B PUM2 APOB PKD1L3 MTTP AFF1 MGA OR4A4P	3.52e-03	848	106	9	EFO_0004614

Protein segments in the cluster

Peptide	Gene	Start	Entry
SDFENYIKTISTTIS	ALOX5AP	141	P20292
SYVTLSTRETFSKVG	EPG5	806	Q9HCE0
TETELKTTDYSVLTT	VCAN	2146	P13611
EYLKSTFSKTDSITT	CASZ1	426	Q86V15
QTFLTVEKYEATSTS	ASAH2B	76	P0C7U1
VSSTCTKVLYFTDRS	DIXDC1	596	Q155Q3
ESTTYLSTSKTTTIL	ADGRV1	5156	Q8WXG9
SDSSSYNIVTKFERT	BNC1	321	Q01954
YSATLSTKSISFTRA	ANKRD13C	326	Q8N6S4
FRVSETTKSADRVTY	AKAP11	1561	Q9UKA4
SKSEDSAEAYTSRSK	ADAM32	761	Q8TC27
RKYSSCSTIFLDDST	CCNY	96	Q8ND76
TTYKVSSLSSSLSVE	AHDC1	491	Q5TGY3
VTSSEASKFIYRDES	CNTN5	826	O94779
TVSGRYKSTTSVSEE	PAWR	221	Q96IZ0
YKSTTSVSEEDVSSR	PAWR	226	Q96IZ0
ESLSTSSDLYKRSSS	PUM2	586	Q8TB72
TKITTTSTYISASTL	KAT6B	411	Q8WYB5
TTRTFGESSKSSYEL	PCDH19	626	Q8TAB3
TKEASTYTLTVETTS	MUC16	141	Q8WXI7
LKTTSRATLTTSVYT	MUC16	10486	Q8WXI7
SSLTQEKVSSVFYTT	OR8D4	266	Q8NGM9
SSSSKYFLTSESTRR	GJC3	226	Q8NFK1
RTSFSASAKYKSEDT	DCC	886	P43146
IKNESISSETSRYSF	PTPRB	596	P23467
ISSETSRYSFHSLKS	PTPRB	601	P23467
KLSYSTSQEFSSREE	FAM171A1	416	Q5VUB5
FSELLAVSSTTYVST	FANCF	11	Q9NPI8
SLTTFSTKSEVDETY	HCFC2	546	Q9Y5Z7
ETSTKTTRTPDTSTY	MAP1B	2026	P46821
KEDTPTSSRTLTYYT	SLC24A1	141	O60721
VKSTIISRYAFTTVS	ITIH5	56	Q86UX2
TAISDVETKETTYSS	MGA	1616	Q8IWI9
VETKETTYSSGATTT	MGA	1621	Q8IWI9
SLSSDTSALSYDSVK	MAPK8IP1	366	Q9UQF2
QTFLTVEKYEATSTS	ASAH2	691	Q9NR71
EDYKAPTASSFTTRT	ASAP2	16	O43150
YESESVKLSVSTTSK	DOP1B	1556	Q9Y3R5
DLFDAITSSTKYTER	DCLK2	476	Q8N568
SNSSTFTKSLSRYES	PLXNA1	1611	Q9UIW2
SSKATSVTTYKIEDS	MTTP	211	P55157
TSTVTDSTTKIAYST	MUC3A	341	Q02505
TLTKSRSFTSSYAIS	PDE3A	486	Q14432
LVSSTSSLYSTAEEK	NAV3	1551	Q8IVL0
KSRLSSVSVTYCSVS	ETS2	241	P15036
SSHTYTRTERTEISK	FLNC	2181	Q14315
EDFYTTFSLVTDKSL	NRXN3	1426	Q9Y4C0
YSFFTTVTVETTEIS	LRRC4	451	Q9HBW1
SSSDIVESSTSYIKI	HEG1	576	Q9ULI3
KNSTYSRSSVDVLYT	HPSE	161	Q9Y251
IDKDTSSSRLSFSSY	PLBD1	266	Q6P4A8
SSATSYSSEFSKRLL	EXOC7	531	Q9UPT5
YRSSARESKSTTLTV	RIMS1	926	Q86UR5
YVTLTSKSSRFTDET	FBXO43	16	Q4G163
TSESESKIFERATSF	ARHGAP29	936	Q52LW3
LSLESLTSYFSIESS	APOB	3481	P04114
ESVSTIITAESIFYK	GATAD1	131	Q8WUU5
YSKTNTSSTIFEKAR	DEFB112	16	Q30KQ8
SYSTLKAVTTRATVS	EPHA8	486	P29322
KDTSSRVIQSVTSYT	DNAJC6	46	O75061
SKDSTYSLSSTLTLS	IGKC	61	P01834
TSSTKTIRRSYFEVF	CYBB	191	P04839
AYAETEKKTRTDSTS	DYNC1H1	4356	Q14204
ESLTYASTTFKLSEE	C1orf162	116	Q8NEQ5
SDSSVTTYTGSYRKK	C4orf51	41	C9J302
TSKTTTSVYLLFITS	NLRP6	411	P59044
IRTASASSSKSFDYV	FAM126B	446	Q8IXS8
DSRTAGTYTVSVFTK	ITK	266	Q08881
RTFSIDKSVSVFYTV	OR4A4P	261	Q8NGN8
SKTTTAVYVFFLSSL	NLRP3	436	Q96P20
STSTFKVTRDSRTYS	IGF2R	1821	P11717
TETTKYVFTDISYSI	MRPS22	151	P82650
SSKTDSFSKLAREYT	RTN4	876	Q9NQC3
NSTSYLTEIFKSTSI	HHLA1	161	C9JL84
DFSSVTKERTTFTDT	USH2A	5186	O75445
RSTESVKSTVSETYL	SRGAP1	406	Q7Z6B7
TVTDTYLSATKVSFD	TRHR	371	P34981
SKTESSSESYKARVA	TAAR6	236	Q96RI8
ETTSSKVESSSESYK	TAAR8	231	Q969N4
KKSSFQITSVTTDYE	TSC22D4	6	Q9Y3Q8
DFYTTFSLVTDKSLS	NRXN3	421	Q9HDB5
SISDYRTFFSSAVTV	PKD1L3	1616	Q7Z443
SFTTTTLDDILKSFS	PTCH1	421	Q13635
SKLSEIVYDSTAVTF	TENM2	2026	Q9NT68
TFYVTKSRDALTETA	STARD9	1746	Q9P2P6
ASRKEDFYTVETITS	OLFML2B	96	Q68BL8
FFTKTEETILVSSSY	SLC10A5	36	Q5PT55
TTSETNKRFSSLSYK	PAG1	286	Q9NWQ8
TLDTSKLYVSSSFTN	RASGRF1	796	Q13972
RKRSYSSSSTEEDTS	SREK1IP1	91	Q8N9Q2
TSKYSVAISTSEVGT	TASOR	851	Q9UK61
IVKSKSESETYTLSS	ADGRE3	616	Q9BY15
SSKSAYSVYSETVDL	AFF1	1011	P51825
TSVTSESEQEFLYKT	CD207	231	Q9UJ71
VTTASTYLFEATEKR	CLCA4	56	Q14CN2
ETITSLYKTSFRVDV	CLCNKA	261	P51800
ETITSLYKTSFRVDV	CLCNKB	261	P51801
AKSSSSRFTDSKRYE	SINHCAF	21	Q9NP50
STSQRKETSTTRYSD	XIRP2	241	A4UGR9
TSDKKDSFYTDSSSI	UHRF1BP1L	996	A0JNW5
FYEVVESSLRSLSSS	SPATA2	66	Q9UM82
TSTSYLSKTLFEITV	VEGFC	176	P49767
SLLAKFSEDTLSSYT	TMEM94	356	Q12767
RKTYTISHTSVSDTI	RYR3	2001	Q15413
TSKYLTDSEYTEGST	TRPV2	101	Q9Y5S1
TSSYASGKESTTFIE	PIGH	101	Q14442
VLTSSKIYYSEETSS	PLCG1	511	P19174
YEKSVSSLSATSELV	ZNF518A	546	Q6AHZ1
TFKSFEERVETTVTS	TPD52L1	146	Q16890
TLNVTYESTKDTFTV	USP24	961	Q9UPU5
ATDITSTRSLNYKST	ZC3HAV1	436	Q7Z2W4
VDLESRKTTYTSDVS	WDR73	161	Q6P4I2
RKTTYTSDVSDSEEL	WDR73	166	Q6P4I2
FKTLSEQLSVTTSTY	MYO5B	941	Q9ULV0
ETITKIYETTTTRTS	NEB	26	P20929